Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

How different terminology for ductal carcinoma in situ impacts women's concern and treatment preferences: a randomised comparison within a national community survey.

McCaffery K, Nickel B, Moynihan R, Hersch J, Teixeira-Pinto A, Irwig L, Barratt A.

BMJ Open. 2015 Nov 2;5(11):e008094. doi: 10.1136/bmjopen-2015-008094.

2.

How different terminology for ductal carcinoma in situ (DCIS) impacts women's concern and management preferences: A qualitative study.

Nickel B, Barratt A, Hersch J, Moynihan R, Irwig L, McCaffery K.

Breast. 2015 Oct;24(5):673-9. doi: 10.1016/j.breast.2015.08.004. Epub 2015 Sep 12.

PMID:
26376460
3.

"Well, have I got cancer or haven't I?" The psycho-social issues for women diagnosed with ductal carcinoma in situ.

De Morgan S, Redman S, White KJ, Cakir B, Boyages J.

Health Expect. 2002 Dec;5(4):310-8.

4.

Selection of treatment among Latina and non-Latina white women with ductal carcinoma in situ.

Kaplan CP, NĂ¡poles AM, Hwang ES, Bloom J, Stewart S, Nickleach D, Karliner L.

J Womens Health (Larchmt). 2011 Feb;20(2):215-23. doi: 10.1089/jwh.2010.1986. Epub 2010 Dec 3.

5.

Eliminating "ductal carcinoma in situ" and "lobular carcinoma in situ" (DCIS and LCIS) terminology in clinical breast practice: The cognitive psychology point of view.

Pravettoni G, Yoder WR, Riva S, Mazzocco K, Arnaboldi P, Galimberti V.

Breast. 2016 Feb;25:82-5. doi: 10.1016/j.breast.2015.10.011. Epub 2015 Nov 21.

PMID:
26614547
6.

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.

Elshof LE, Tryfonidis K, Slaets L, van Leeuwen-Stok AE, Skinner VP, Dif N, Pijnappel RM, Bijker N, Rutgers EJ, Wesseling J.

Eur J Cancer. 2015 Aug;51(12):1497-510. doi: 10.1016/j.ejca.2015.05.008. Epub 2015 May 26.

7.

The challenge of being diagnosed and treated for ductal carcinoma in situ (DCIS).

Kennedy F, Harcourt D, Rumsey N.

Eur J Oncol Nurs. 2008 Apr;12(2):103-11. Epub 2007 Nov 26.

PMID:
18023255
8.

Understanding a ductal carcinoma in situ diagnosis: patient views and surgeon descriptions.

Davey C, White V, Warne C, Kitchen P, Villanueva E, Erbas B.

Eur J Cancer Care (Engl). 2011 Nov;20(6):776-84. doi: 10.1111/j.1365-2354.2011.01265.x. Epub 2011 Jul 19.

PMID:
21771131
9.
10.

Impact of ductal carcinoma in situ terminology on patient treatment preferences.

Omer ZB, Hwang ES, Esserman LJ, Howe R, Ozanne EM.

JAMA Intern Med. 2013 Oct 28;173(19):1830-1. doi: 10.1001/jamainternmed.2013.8405. No abstract available.

PMID:
23978843
11.

What quality-of-life issues do women with ductal carcinoma in situ (DCIS) consider important when making treatment decisions?

Mercieca-Bebber R, King MT, Boxer MM, Spillane A, Winters ZE, Butow PN, McPherson J, Rutherford C.

Breast Cancer. 2017 Sep;24(5):720-729. doi: 10.1007/s12282-017-0765-0. Epub 2017 Feb 28.

PMID:
28247220
12.

Addressing overtreatment of screen detected DCIS; the LORIS trial.

Francis A, Thomas J, Fallowfield L, Wallis M, Bartlett JM, Brookes C, Roberts T, Pirrie S, Gaunt C, Young J, Billingham L, Dodwell D, Hanby A, Pinder SE, Evans A, Reed M, Jenkins V, Matthews L, Wilcox M, Fairbrother P, Bowden S, Rea D.

Eur J Cancer. 2015 Nov;51(16):2296-303. doi: 10.1016/j.ejca.2015.07.017. Epub 2015 Aug 18.

PMID:
26296293
13.

Ductal carcinoma in situ: treatment or active surveillance?

Kuerer HM.

Expert Rev Anticancer Ther. 2015;15(7):777-85. doi: 10.1586/14737140.2015.1043897. Epub 2015 May 4. Review.

PMID:
25938920
14.

The shifting nature of women's experiences and perceptions of ductal carcinoma in situ.

Kennedy F, Harcourt D, Rumsey N.

J Adv Nurs. 2012 Apr;68(4):856-67. doi: 10.1111/j.1365-2648.2011.05788.x. Epub 2011 Jul 25.

PMID:
21790736
15.

Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ.

Bluman LG, Borstelmann NA, Rimer BK, Iglehart JD, Winer EP.

J Womens Health Gend Based Med. 2001 Jul-Aug;10(6):589-98.

PMID:
11559456
16.

Diagnosis and management of ductal carcinoma in situ (DCIS).

Virnig BA, Shamliyan T, Tuttle TM, Kane RL, Wilt TJ.

Evid Rep Technol Assess (Full Rep). 2009 Sep;(185):1-549. Review.

17.

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.

Narod SA, Iqbal J, Giannakeas V, Sopik V, Sun P.

JAMA Oncol. 2015 Oct;1(7):888-96. doi: 10.1001/jamaoncol.2015.2510.

PMID:
26291673
18.

Ductal carcinoma in situ: terminology, classification, and natural history.

Allred DC.

J Natl Cancer Inst Monogr. 2010;2010(41):134-8. doi: 10.1093/jncimonographs/lgq035. Review.

19.

Treatment of ductal carcinoma in situ: an uncertain harm-benefit balance.

[No authors listed]

Prescrire Int. 2013 Dec;22(144):298-303. Review.

PMID:
24600734
20.

Prospective changes in quality of life after ductal carcinoma-in-situ: results from the Nurses' Health Study.

Nekhlyudov L, Kroenke CH, Jung I, Holmes MD, Colditz GA.

J Clin Oncol. 2006 Jun 20;24(18):2822-7.

PMID:
16782920

Supplemental Content

Support Center